Search

Grzegorz Boratyn Phones & Addresses

  • Washington, DC
  • 1327 Hepburn Ave, Louisville, KY 40204
  • 1703 4Th St, Louisville, KY 40208
  • 1709 4Th St, Louisville, KY 40208

Publications

Us Patents

Peptide Biomarkers Predictive Of Renal Function Decline And Kidney Disease

View page
US Patent:
8394601, Mar 12, 2013
Filed:
Sep 16, 2011
Appl. No.:
13/234756
Inventors:
Jon B. Klein - Louisville KY, US
Michael Merchant - Louisville KY, US
Grzegorz Boratyn - Louisville KY, US
Assignee:
University of Louisville Research Foundation, Inc. - Louisville KY
International Classification:
C07K 7/00
G01N 33/53
H01J 49/26
H01J 49/40
US Classification:
435 792, 530326, 530327, 530328, 530329, 5303871, 436501
Abstract:
Methods and kits are provided for diagnosing a kidney disease, or the risk thereof, in a subject. The methods include determining an amount of at least one peptide biomarker disclosed herein in a biological sample from the subject and comparing the amount of the at least one peptide in the sample with a control level, wherein if the amount determined is different than the control level, the subject is diagnosed as having, or at an increased risk of developing, the kidney disease.

Peptide Biomarkers Predictive Of Renal Function Decline And Kidney Disease

View page
US Patent:
20090081713, Mar 26, 2009
Filed:
Sep 19, 2008
Appl. No.:
12/234401
Inventors:
Jon B. Klein - Louisville KY, US
Michael Merchant - Louisville KY, US
Grzegorz Boratyn - Washington DC, US
Assignee:
UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. - Louisville KY
International Classification:
G01N 33/53
C12Q 1/02
G01N 33/68
C07K 16/18
H01J 49/26
US Classification:
435 792, 435 29, 436 86, 5303879, 5303911, 250282
Abstract:
The presently-disclosed subject matter provides methods for diagnosing a kidney disease, or the risk thereof, in a subject. The methods comprise determining an amount of at least one peptide biomarker disclosed herein in a biological sample from the subject and comparing the amount of the at least one peptide in the sample with a control level, wherein if the amount determined is different than the control level, the subject is diagnosed as having, or at an increased risk of developing, the kidney disease.
Grzegorz M Boratyn from Washington, DC, age ~48 Get Report